| Literature DB >> 27576175 |
Alper Tunga Özdemir1, Rabia Bilge Özgül Özdemir2, Cengiz Kırmaz3, Ayla Eker Sarıboyacı4, Zehra Seda Ünal Halbutoğlları5, Ceren Özel5, Erdal Karaöz6.
Abstract
Mesenchymal stem cells (MSCs) have strong immunomodulatory properties, however these properties may show some differences according to the tissue type of their isolate. In this study we investigated the paracrine interactions between human DP derived MSCs (hDP-MSCs) and the CD4+ T helper cell subsets to establish their immunomodulatory mechanisms. We found that the CD4+-Tbet+ (Th1) and CD4+-Gata3+ (Th2) cells were suppressed by the hDP-MSCs, but the CD4+-Stat3+ (Th17) and CD4+-CD25+-FoxP3+ (Treg) cells were stimulated. The expressions of T cell specific cytokines interferon gamma (IFN-g), interleukin (IL)-4 and IL-17a decreased, but IL-10 and transforming growth factor beta-1 (TGF-b1) increased with the hDP-MSCs. The expressions of indoleamine-pyrrole 2,3-dioxygenase (IDO), prostaglandin E2 (PGE2), soluble human leukocyte antigen G (sHLA-G) derived from hDP-MSCs slightly increased, but hepatocyte growth factor (HGF) significantly increased in the co-culture groups. According to our findings, the hDP-MSCs can suppress the Th1 and Th2 subsets but stimulate the Th17 and Treg subsets. The Stat3 expression of Th17 cells may have been stimulated by the HGF, and thus the pro-inflammatory Th17 cells may have altered into the immunosuppressive regulatory Th17 cells. Further prospective studies are needed to confirm our findings. Copyright ÂEntities:
Keywords: CD(4) T cell; FoxP3; Gata3; Hepatocyte growth factor; Immunomodulation; Interleukin; Mesenchymal stem cell; Stat3; T-bet
Mesh:
Substances:
Year: 2016 PMID: 27576175 DOI: 10.1016/j.cellimm.2016.08.008
Source DB: PubMed Journal: Cell Immunol ISSN: 0008-8749 Impact factor: 4.868